Schedule 13G ownership disclosure

ATRINSIC INC

Security class unavailable · CUSIP: 04964C208

Event date: 2015-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
44,395,067
Percent of class
9.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001393825-16-000035
Form type
SC 13G/A
Filer
Protagenic Therapeutics, Inc.\new
CIK
CIK 1022899
Filed
Feb 08, 2016
Reporting period
Dec 31, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub